Your browser is no longer supported. Please, upgrade your browser.
Settings
NVTA Invitae Corporation daily Stock Chart
NVTA [NYSE]
Invitae Corporation
Index- P/E- EPS (ttm)-2.23 Insider Own1.20% Shs Outstand93.03M Perf Week-3.00%
Market Cap1.60B Forward P/E- EPS next Y-2.31 Insider Trans-13.83% Shs Float92.42M Perf Month-1.27%
Income-194.90M PEG- EPS next Q-0.67 Inst Own87.70% Short Float19.93% Perf Quarter-21.25%
Sales195.90M P/S8.15 EPS this Y-20.90% Inst Trans7.24% Short Ratio10.07 Perf Half Y-16.37%
Book/sh4.23 P/B4.06 EPS next Y-1.30% ROA-38.00% Target Price29.17 Perf Year37.61%
Cash/sh5.02 P/C3.42 EPS next 5Y8.00% ROE-63.70% 52W Range9.04 - 28.75 Perf YTD55.15%
Dividend- P/FCF- EPS past 5Y-18.20% ROI-50.00% 52W High-40.31% Beta2.54
Dividend %- Quick Ratio7.40 Sales past 5Y297.90% Gross Margin47.70% 52W Low89.82% ATR1.05
Employees1100 Current Ratio7.40 Sales Q/Q51.10% Oper. Margin-97.40% RSI (14)43.94 Volatility5.28% 5.45%
OptionableYes Debt/Eq0.66 EPS Q/Q-82.10% Profit Margin-99.50% Rel Volume0.48 Prev Close17.03
ShortableYes LT Debt/Eq0.66 EarningsNov 06 AMC Payout- Avg Volume1.83M Price17.16
Recom1.70 SMA20-7.74% SMA50-4.24% SMA200-19.44% Volume884,046 Change0.76%
Aug-07-19Reiterated The Benchmark Company Buy $26 → $28
Mar-04-19Initiated Chardan Capital Markets Buy $29
Dec-19-18Initiated Oppenheimer Outperform
Nov-20-18Resumed The Benchmark Company Buy $17
Feb-13-18Reiterated The Benchmark Company Buy $11 → $10
Jan-16-18Reiterated The Benchmark Company Buy $16 → $11
Jan-16-18Reiterated Leerink Partners Outperform $12 → $10
Jan-05-18Initiated Ladenburg Thalmann Buy $15
Apr-03-17Reiterated The Benchmark Company Buy $11 → $16
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Dec-13-19 03:27PM  Hedge Funds Are Selling InVitae Corporation (NVTA) Insider Monkey
Dec-10-19 07:30AM  Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias PR Newswire
Dec-09-19 05:27AM  Bull of the Day: Guardant Health (GH) Zacks
Dec-06-19 09:15AM  Stocks Rebound and Hang Onto Recent Gains Zacks
09:04AM  Genetic Testing Companies Take DNA Tests To A Whole New Level Investor's Business Daily
Dec-04-19 01:54PM  Invitae (NYSE:NVTA) Has Debt But No Earnings; Should You Worry? Simply Wall St. -6.66%
Nov-21-19 07:30AM  Invitae to Participate in the 31st Annual Piper Jaffray Healthcare Conference PR Newswire
Nov-15-19 08:14AM  Invitae Launches Invitae Discover Research Platform on Apple Watch; First Study on Platform Will Investigate Genetic Causes of Cardiovascular Disease PR Newswire +7.65%
Nov-13-19 03:08PM  The Funded: Two hefty rounds lead $800M in Bay Area startup funding at midweek American City Business Journals
Nov-12-19 04:38PM  Edited Transcript of NVTA earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 08:11PM  This simple acquisition shows how genetic testing is consolidating, cozying up to doctors and patients American City Business Journals +6.02%
07:30AM  Invitae to Acquire Clear Genetics PR Newswire
Nov-08-19 05:59PM  University of Vermont Health Network begins offering Genomic DNA Testing PR Newswire +11.72%
02:58PM  The Unloved Biotechnology ETF Rally ETF Trends
Nov-07-19 01:13AM  Stocks Take a Rest from Setting All-Time Highs Zacks -5.30%
Nov-06-19 07:45PM  Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM  Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples PR Newswire
Nov-05-19 07:30AM  Invitae Highlights Importance of Medical Genetics, Honors Excellence in Genetic Counseling at National Society of Genetic Counselors (NSGC) 38th Annual Conference PR Newswire
Oct-31-19 07:34AM  Will Genetic Testing Drive Invitae's (NVTA) Q3 Earnings? Zacks
04:30AM  8 Undervalued Biotech Stocks to Watch Now Investopedia
Oct-30-19 10:33AM  Earnings Preview: Invitae (NVTA) Q3 Earnings Expected to Decline Zacks
Oct-27-19 04:16PM  Is InVitae Corporation (NVTA) A Good Stock To Buy? Insider Monkey
Oct-23-19 07:30AM  Invitae to announce third quarter 2019 financial results on November 6, 2019 PR Newswire
Oct-17-19 11:17AM  InVitae Shares Bounce Back Following Analyst Rebuttal To Short Seller Allegations Benzinga
07:30AM  Research presented by Invitae at the American Society of Human Genetics Meeting Pushes Science and Practice of Genetics Forward PR Newswire
Oct-02-19 09:15AM  Rough Start to Fourth Quarter Zacks
Sep-27-19 12:19PM  Does Invitae Corporation's (NYSE:NVTA) CEO Pay Matter? Simply Wall St.
Sep-26-19 03:03PM  Edited Transcript of NVTA earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-25-19 03:34PM  5 Top Stock Trades for Thursday: NVDA, MTCH, NVTA InvestorPlace
Sep-13-19 05:50PM  Invitae (NVTA) Dips More Than Broader Markets: What You Should Know Zacks
Sep-09-19 07:30AM  Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients PR Newswire
Sep-06-19 07:00AM  Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes PR Newswire
Sep-04-19 04:05PM  Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes PR Newswire
Sep-03-19 03:48PM  4 Top Stock Trades for Wednesday: TWTR, WMT, CLF, NVTA InvestorPlace -6.55%
Aug-29-19 09:15AM  Dow Jumps 1% Despite Yield Curve Worries Zacks
Aug-21-19 08:15PM  Invitae Corp (NVTA) COO E Lee Bendekgey Sold $537,792 of Shares GuruFocus.com
Aug-20-19 07:30AM  Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients GlobeNewswire
Aug-16-19 12:04PM  Citron Favorite Flashes Buy Signal Schaeffer's Investment Research
Aug-13-19 02:46PM  Are Insiders Selling Invitae Corporation (NYSE:NVTA) Stock? Simply Wall St. +5.80%
Aug-08-19 02:59PM  Disruptive Health Care ETF Is Good For Your Genes ETF Trends
Aug-07-19 03:37PM  5 Top Stock Trades for Thursday: TLT, WW, CVS, NVTA, MU InvestorPlace +7.55%
Aug-06-19 10:24PM  Invitae Corp (NVTA) Q2 2019 Earnings Call Transcript Motley Fool
05:55PM  Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:15PM  Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume PR Newswire
01:13AM  Worst Day of the Year as China Punches Back Zacks
Aug-05-19 04:20PM  Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July Motley Fool -6.51%
Aug-02-19 08:50AM  Implied Volatility Surging for Invitae (NVTA) Stock Options Zacks
04:53AM  Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts TheStreet.com
Jul-31-19 02:41PM  Citron Thinks This Stock Could Quadruple Schaeffer's Investment Research
08:50AM  Short Seller Left Goes Long on Invitae With $100 Target TheStreet.com
Jul-30-19 03:51PM  5 Top Stock Trades for Wednesday: UAA, PEP, NVTA InvestorPlace +5.51%
10:38AM  Analysts Estimate Invitae (NVTA) to Report a Decline in Earnings: What to Look Out for Zacks
09:23AM  Will Genetic Testing Drive Invitae's (NVTA) Q2 Earnings? Zacks
Jul-29-19 05:50PM  Invitae (NVTA) Gains As Market Dips: What You Should Know Zacks
Jul-24-19 07:30AM  Invitae Launches Detect Programs to Make it Easier for Patients to Get Genetic Testing for Prostate Cancer, Muscular Dystrophy and Heart Conditions PR Newswire
07:15AM  Bear of the Day: Illumina (ILMN) Zacks
Jul-23-19 05:50PM  Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know Zacks
07:30AM  Invitae to announce second quarter 2019 financial results on August 6, 2019 PR Newswire
Jul-17-19 03:41PM  5 Top Stock Trades for Thursday: TSLA, GLD, ABT InvestorPlace
01:26PM  [video]Invitae Shares Rise After Famed Short-Seller Andrew Left Goes Long the Stock TheStreet.com
Jul-12-19 05:50PM  Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know Zacks
04:29PM  Nasdaq Today: Amazon Prime Day; Facebook Settles With FTC InvestorPlace
12:31PM  InVitae Analyst: Acquisition Beefs Up Company's Hereditary Cancer Testing Capacity Benzinga
Jul-11-19 04:06PM  Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients PR Newswire
Jul-04-19 10:26AM  3 Healthcare Stocks Ready to Grow TipRanks
Jul-01-19 10:55AM  Invitae (NVTA) Catches Eye: Stock Jumps 9.1% Zacks
09:15AM  Stocks Soar 7% in June Zacks
Jun-27-19 02:00PM  Capital Market Laboratories (CMLviz) Interviews Invitaes CEO Invitaes Non-Invasive Prenatal Screening Tests Can be a 50% Gross Margin Business GlobeNewswire +6.79%
Jun-24-19 04:23PM  Why These Innovative Biotech ETFs Soaring Zacks
Jun-21-19 03:19PM  5 Top Stock Trades for Monday: AAPL, XOM, NVTA InvestorPlace
10:42AM  The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health Zacks
Jun-20-19 09:00PM  Invitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of Acquisition PR Newswire
Jun-19-19 06:41PM  46 and You: Genetic Testing = Giant Growth Market Zacks
Jun-18-19 09:15AM  Fed Week Begins in the Green Zacks
Jun-17-19 02:53PM  Invitae Will Acquire Singular Bio For $55M Benzinga +6.71%
07:30AM  Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy PR Newswire
Jun-14-19 09:35AM  Were Hedge Funds Right About Flocking Into InVitae Corporation (NVTA) ? Insider Monkey
Jun-12-19 08:30AM  X4 Pharmaceuticals and Invitae Announce Partnership to Provide No-Cost Genetic Testing to Patients Suspected of Primary Immunodeficiency Disease Business Wire
07:30AM  Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders PR Newswire
Jun-11-19 10:21AM  It's a genetic jungle out there and this Peninsula company just landed $23M to guide patients through it American City Business Journals
Jun-04-19 01:36PM  Here's Why Genetic Testing Stocks Lost as Much as 26.1% in May Motley Fool
Jun-03-19 08:56PM  Edited Transcript of NVTA earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
09:15AM  A May to Forget Zacks
07:30AM  Invitae introduces new service to make it easier for consumers to receive the medical genetic testing that experts trust PR Newswire
May-31-19 07:30AM  Research from Invitae Demonstrates the Importance of Germline Multigene Panel Testing in Guiding Therapy for Expanding Groups of Cancer Patients PR Newswire
May-29-19 08:00AM  Horizon Therapeutics plc and Invitae Corporation Launch Urea Cycle Disorder Genetic Testing Program Business Wire
May-28-19 05:43AM  Bull of the Day: Illumina (ILMN) Zacks
May-22-19 07:30AM  Invitae to Present at the 2019 William Blair Growth Stock Conference PR Newswire
May-20-19 06:00AM  Can Invitae Succeed in Genetic Diagnostics MoneyShow
May-17-19 10:56PM  3 High-Growth Stocks That Are Just Getting Started Motley Fool
May-15-19 07:30AM  Invitae to Present at the UBS Global Healthcare Conference PR Newswire
May-09-19 10:01AM  Were Invitae's Quarterly Results Really That Bad? Motley Fool
07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-08-19 06:14PM  2 Healthcare Innovators To Buy Now Zacks -20.16%
12:30PM  Here's Why Invitae Got Crushed Today Motley Fool
May-07-19 11:23PM  Invitae Corp (NVTA) Q1 2019 Earnings Call Transcript Motley Fool
07:45PM  Invitae (NVTA) Reports Q1 Loss, Lags Revenue Estimates Zacks
06:41PM  Invitae: 1Q Earnings Snapshot Associated Press
04:52PM  Invitae stock falls more than 10% after revenue miss MarketWatch
04:05PM  Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year PR Newswire
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. Its tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; and screening and testing services in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company also operates AltaVoice, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stueland KatherineChief Commercial OfficerNov 14Sale17.463,78866,123136,053Nov 15 09:42 PM
Stueland KatherineChief Commercial OfficerSep 17Sale21.403,78881,081139,841Sep 18 06:00 PM
Scott Randal WExecutive ChairmanAug 26Sale24.5940,000983,4053,450,669Aug 27 07:18 PM
Crouse GeoffreyDirectorAug 22Sale25.685,000128,41029,259Aug 26 08:34 PM
Guyer Shelly DChief Financial OfficerAug 19Sale25.3824,447620,574122,905Aug 21 06:36 PM
BENDEKGEY E LEEChief Operating OfficerAug 19Sale25.2921,265537,883140,323Aug 21 06:35 PM
George Sean EPresident & CEOAug 19Sale25.2916,358413,764463,649Aug 21 06:33 PM
Nussbaum Robert LChief Medical OfficerAug 19Sale25.2920,447517,193146,120Aug 21 06:33 PM
Brida ThomasGeneral CounselAug 19Sale25.2913,663345,59695,870Aug 21 06:32 PM
Stueland KatherineChief Commercial OfficerAug 19Sale25.2922,900579,239143,629Aug 21 06:33 PM
Stueland KatherineChief Commercial OfficerAug 16Sale24.983,78994,645166,529Aug 19 05:47 PM
Stueland KatherineChief Commercial OfficerJul 15Sale22.493,78985,231170,318Jul 16 05:49 PM
Stueland KatherineChief Commercial OfficerJun 13Sale19.363,78973,356174,107Jun 14 09:32 PM
Scott Randal WExecutive ChairmanMay 28Sale17.6030,000528,0273,490,669May 30 07:23 PM
Stueland KatherineChief Commercial OfficerMay 20Sale18.216,474117,892177,896May 22 08:08 PM
Brida ThomasGeneral CounselMay 20Sale18.212,14639,079109,533May 22 08:06 PM
BENDEKGEY E LEEChief Operating OfficerMay 20Sale18.216,851124,757161,588May 22 08:03 PM
George Sean EPresident & CEOMay 20Sale18.2124,282442,175480,007May 22 08:02 PM
Guyer Shelly DChief Financial OfficerMay 20Sale18.039,513171,539147,352May 22 07:59 PM
Nussbaum Robert LChief Medical OfficerMay 20Sale18.217,202131,148166,567May 22 07:58 PM
Stueland KatherineChief Commercial OfficerMay 15Sale18.361,00018,360184,370May 17 07:58 PM
BENDEKGEY E LEEChief Operating OfficerMay 14Sale18.784,65787,439168,439May 15 07:28 PM
Stueland KatherineChief Commercial OfficerApr 16Sale25.231,00025,230185,370Apr 17 08:17 PM
Stueland KatherineChief Commercial OfficerMar 15Sale23.491,00023,490186,370Mar 19 09:24 PM
Nussbaum Robert LChief Medical OfficerMar 08Option Exercise9.9010,00099,000173,769Mar 12 07:17 PM
Guyer Shelly DChief Financial OfficerFeb 27Sale20.004,00080,018156,865Mar 01 07:24 PM
Stueland KatherineChief Commercial OfficerFeb 27Sale19.611,00019,610187,370Mar 01 07:21 PM
Dumond PattySee RemarksFeb 27Sale19.715,00098,54088,811Mar 01 07:20 PM
BENDEKGEY E LEEChief Operating OfficerFeb 26Sale19.624,65091,213173,096Feb 27 09:26 PM
Scott Randal WExecutive ChairmanFeb 25Sale19.1030,000572,9973,520,669Feb 27 02:13 PM
Dumond PattySee RemarksJan 16Sale15.003,00045,00093,811Jan 18 05:37 PM
Guyer Shelly DChief Financial OfficerJan 16Sale14.494,00057,968160,865Jan 18 05:34 PM
Stueland KatherineChief Commercial OfficerJan 15Sale13.591,00013,590188,370Jan 16 04:39 PM
Nussbaum Robert LChief Medical OfficerJan 10Sale14.015,22273,153163,769Jan 14 09:13 PM
Stueland KatherineChief Commercial OfficerDec 17Sale11.441,00011,437189,370Dec 19 08:08 PM